HK Stock MarketDetailed Quotes

TYK MEDICINES-B (02410)

Watchlist
  • 8.450
  • +0.290+3.55%
Not Open May 19 16:05 CST
3.21BMarket Cap-9.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

TYK MEDICINES-B (02410) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2024/FY
Stock NameRevenueRatio
开发及商业化医药产品107K100.00%

By Product

Currency:CNY
2024/FY
Stock NameRevenueRatio
开发及商业化医药产品107K100.00%

By Country/Region

No Data

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.54%
Sample Name
Sample Code
 +4.71%
Sample Name
Sample Code
 0.00%
4
SHANGHAI PECHEM
00338
-0.81%
5
SINOPEC CORP
00386
-0.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +42.01%
Sample Name
Sample Code
 +32.82%
Sample Name
Sample Code
 +26.86%
4
Emdoor Information
001314
+25.83%
5
Digital China Group
000034
+20.88%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -